ACE and angioedema: Nineteen cases of angioedema have been reported by vildagliptin among which 73% were using ACE inhibitors concurrently, in one meta-analysis no significant increase in angioedema risk was seen with vildagliptin (without ACE inhibitors) compared to placebo or other oral hypoglycemic agents.